A multicenter retrospective review of antibiotic prescribing patterns for treatment of urinary tract infections in the primary care setting

被引:1
|
作者
Mullakary, Jenny [1 ,2 ,6 ]
Visintainer, Sarah [1 ,3 ,7 ]
Tucci, Mitchell [1 ,4 ,8 ]
Dionne, Brandon [1 ,5 ]
Conley, Michael P. [1 ,2 ]
Reid, Debra J. [1 ,4 ]
Matta, Thomas M. [1 ,2 ]
Bartucca, Macayla A. [1 ,3 ]
Bouwmeester, Carla J. [1 ,3 ]
机构
[1] Northeastern Univ, Dept Pharm & Hlth Syst Sci, 360 Huntington Ave,140 Fenway R218, Boston, MA 02115 USA
[2] Harbor Hlth Serv Inc, Mattapan, MA USA
[3] Harbor Hlth Elder Serv Plan, Mattapan, MA USA
[4] Dimock Ctr, Roxbury, MA USA
[5] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[6] Atrius Hlth, Clin Pharm Dept, Watertown, MA USA
[7] Shields Hlth Solut, Clin Pharm Dept, Stoughton, MA USA
[8] CVS Pharm, Pharm Dept, Boston, MA USA
来源
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | 2021年 / 4卷 / 06期
关键词
anti-bacterial agents; drug resistance; fluoroquinolones; pharmacists; primary care; urinary tract infections;
D O I
10.1002/jac5.1430
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction It has been estimated that nearly 50% of antibiotics are inappropriately prescribed in the outpatient setting. Despite much discussion surrounding the importance of reducing these occurrences, the literature is limited in describing antibiotic prescribing patterns for urinary tract infections (UTIs) in the primary care setting. Objectives The primary objective of this study was to evaluate if antibiotics for UTIs in primary care settings are prescribed concordantly with evidence-based guidelines. Methods This retrospective cohort study reviewed female patients 18 years and older treated in a primary care setting with a diagnosis of uncomplicated UTI. Treatment was analyzed for appropriateness of empiric antibiotic choice, duration of therapy, and dose. This information was then compared with treatment recommendations for UTIs per the 2010 Infectious Diseases Society of America (IDSA) guidelines. Antibiotic prescribing patterns were also analyzed in relation to the 2016 United States Food and Drug Administration (FDA) safety warning for fluoroquinolones. Results A total of 388 UTI encounters over the 42-month study period were included for analysis. Sulfamethoxazole/trimethoprim was the most frequently prescribed antibiotic (50.0%) followed by nitrofurantoin (26.3%) and fluoroquinolones (16.8%). A total of 71.6% of antibiotic agents selected for treatment of UTIs were not first line agents per the 2010 IDSA guidelines, which increased to 92.3% when considering dosing, duration, and renal adjustments. Culture and susceptibility results led to changes in empiric therapy, yet only 38.1% of the changes were considered guideline concordant. Linear regression comparing pre- and post-FDA warnings indicated a 15% reduction in the proportion of fluoroquinolone prescriptions (P < .001). Conclusion A large disparity exists between antibiotic prescribing patterns and IDSA guideline recommendations. By identifying divergences from standards of practice, pharmacists can justify the need to integrate stewardship programs into primary care settings in order to optimize patient care.
引用
收藏
页码:689 / 696
页数:8
相关论文
共 50 条
  • [21] Consultations and antibiotic treatment for urinary tract infections in Norwegian primary care 2006–2015, a registry-based study
    Lars Emil Aga Haugom
    Sabine Ruths
    Knut Erik Emberland
    Knut Eirik Ringheim Eliassen
    Guri Rortveit
    Knut-Arne Wensaas
    BMC Family Practice, 22
  • [22] Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?
    Aabenhus, Rune
    Jensen, Jens-Ulrik Staehr
    PRIMARY CARE RESPIRATORY JOURNAL, 2011, 20 (04): : 360 - 367
  • [23] OUTPATIENT MANAGEMENT OF URINARY TRACT INFECTIONS IN PRIMARY CARE
    Alqahtani, Abdulaziz Mofleh Ayed
    Alseddik, Hanadi Ali
    Asiri, Sulaiman Nasser Sulaiman
    Fagihi, Matra Mohammed Ali
    Sumayli, Abdullah Taher Hamoud
    Sait, Mahmoud Abdulghafur Mahmoud
    Alshaikh, Turki Tawfik
    Khyat, Abdulaziz Faisal
    Sahhari, Mohammed Abdurahman M.
    Alfattany, Lujain J.
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (01): : 716 - 720
  • [24] Point-of-care tests: the key to reducing antibiotic prescribing for respiratory tract infections in primary care?
    Brown, Emily
    Hay, Alastair D.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024, 24 (03) : 139 - 141
  • [25] ANTIBIOTIC RESISTANCE PATTERNS OF URINARY TRACT INFECTIONS IN A NORTHEASTERN BRAZILIAN CAPITAL
    Cunha, Mirella Alves
    Medeiros Assuncao, Gabriela Lins
    Medeiros, Iara Marques
    Freitas, Marise Reis
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2016, 58
  • [26] Quality indicators for appropriate antibiotic prescribing in urinary tract infections in children
    Vazouras, Konstantinos
    Jackson, Charlotte
    Folgori, Laura
    Anastasiou-Katsiardani, Anastasia
    Hsia, Yingfen
    Basmaci, Romain
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [27] Selective decrease in consultations and antibiotic prescribing for acute respiratory tract infections in UK primary care up to 2006
    Gulliford, Martin
    Latinovic, Radoslav
    Charlton, Judith
    Little, Paul
    van Staa, Tjeerd
    Ashworth, Mark
    JOURNAL OF PUBLIC HEALTH, 2009, 31 (04) : 512 - 520
  • [28] Consultations and antibiotic treatment for urinary tract infections in Norwegian primary care 2006-2015, a registry-based study
    Haugom, Lars Emil Aga
    Ruths, Sabine
    Emberland, Knut Erik
    Eliassen, Knut Eirik Ringheim
    Rortveit, Guri
    Wensaas, Knut-Arne
    BMC FAMILY PRACTICE, 2021, 22 (01)
  • [29] Respiratory tract infections in primary health care: prevalence and antibiotic prescribing in a primary care practice during one year
    Pietrzykowska, Malgorzata
    Nowicka-Sauer, Katarzyna
    Siebert, Janusz
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2021, 23 (02) : 203 - 208
  • [30] Antibiotic Resistance, Polycentricity, and the Regulation of Antibiotic Prescribing in the Primary Care Setting
    Carter, David J.
    LAWS, 2025, 14 (01)